Timothy R. Wilson
- Oncology top 1%
- HER2/EGFR in Cancer Research 14
- Cancer Treatment and Pharmacology 10
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 16
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 12
-
- Advanced Breast Cancer Therapies 18
- Lung Cancer Treatments and Mutations 15
- Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer 26
- Cell death mechanisms and regulation 9
- Co-authors
- Jeff SettlemanDaniel B. LongleyPatrick G. JohnstonMark MerchantMark R. LacknerDavid J. AlexanderLeeona GalliganHartmut Koeppen
- Cited by
- OncologyCancer ResearchGenetics
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Timothy R. Wilson
86 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Oncology 2.2k
- Cancer Research 961
- Genetics 373
- Pulmonary and Respiratory Medicine 1.1k
- Molecular Biology 2.3k
Countries citing papers authored by Timothy R. Wilson
This map shows the geographic impact of Timothy R. Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy R. Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy R. Wilson more than expected).
Fields of papers citing papers by Timothy R. Wilson
This network shows the impact of papers produced by Timothy R. Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy R. Wilson. The network helps show where Timothy R. Wilson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Timothy R. Wilson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 16 | |
| 5 | 2022 | 15 | |
| 6 | 2021 | 111 | |
| 7 | 2020 | 5 | |
| 8 | 2020 | 4 | |
| 9 | 2020 | 116 | |
| 10 | 2020 | 11 | |
| 11 | 2019 | 8 | |
| 12 | 2019 | 4 | |
| 13 | 2018 | 57 | |
| 14 | 2018 | 105 | |
| 15 | 2018 | 15 | |
| 16 | 2017 | 120 | |
| 17 | 2014 | 223 | |
| 18 | 2014 | 21 | |
| 19 | 2011 | 125 | |
| 20 | Interleukin-8/CXCR2 signaling plays an important role in conferring resistance of prostate cancer cells to chemotherapy | 2007 | 2 |
About Timothy R. Wilson
Timothy R. Wilson is a scholar working on Oncology, Cancer Research and Genetics, having authored 88 papers that have together received 4.3k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (26 papers), Advanced Breast Cancer Therapies (18 papers), Cancer Genomics and Diagnostics (16 papers), Lung Cancer Treatments and Mutations (15 papers), HER2/EGFR in Cancer Research (14 papers), Chronic Lymphocytic Leukemia Research (12 papers), Cancer Treatment and Pharmacology (10 papers) and Cell death mechanisms and regulation (9 papers). The work is most often cited by research in Oncology (2.2k citations), Cancer Research (961 citations) and Genetics (373 citations). Timothy R. Wilson has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Jeff Settleman, Daniel B. Longley, Patrick G. Johnston, Mark Merchant, Mark R. Lackner, David J. Alexander, Leeona Galligan, Hartmut Koeppen, Yulei Wang and Miranda McEwan. Their work appears in journals such as Nature, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.